Since 2020, back when she was a seventh-year associate, Desmarais LLP partner Kerri-Ann Limbeek, 36, has represented Maryland prenatal testing company Ravgen against some of the giants of the diagnostic industry. That effort has included litigating eight patent infringement cases in district courts across the country, as well as defending the company in 10 inter partes review proceedings before the Patent Trial and Appeal Board.

In 2022, with firm founding partner John Desmarais sitting first chair, Limbeek was part of a trial team that won a $272.5 million verdict for Ravgen against medical testing giant Labcorp. This week, Limbeek, in her first time as acting lead trial counsel, won a $57 million damages verdict for Ravgen against Natera.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]